Christopher M. Lindblom files SEC Form 4 disclosures for INFINITY PHARMACEUTICALS, INC.. They have made 1 open-market trade across 1 company since 2012, most recently 2012-11-26.
CIK 0001378796
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| INFI | 13,885 | $621 |
Shares reported on the most recent Form 4, priced at the 2012-11-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INFI | SELL | 2012-11-26 | 2012-11-27 | $25.73 | $357K | -22.9% | -10.3% | -10.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.